The article provides an earnings forecast for Waters Corp (WAT), highlighting its current earnings forecast score of 7.67, ranking 128 out of 204 in its industry. Analysts set an average price target of $395.00, with a consensus leaning towards a "Buy" rating based on 25 analysts. The report also details expected revenue for the next quarter at $1.62 billion and provides recent and forecasted EPS figures.

CAVA Group CFO Tricia K. Tolivar sold 4,969 shares worth $444,377 to cover tax obligations from vested restricted stock units, and also purchased 283 shares for $12,488 through an employee stock purchase plan. The company's stock has surged 57% in six months but is considered overvalued by InvestingPro. Cava Group is also expanding with new restaurants and hiring, while analysts have upgraded its stock rating due to strong performance and growth potential.

Ge Vernova Inc (GEV) shares rose 5.87% on June 18, primarily driven by bullish analyst commentary and strong demand from the global energy transition and AI buildout. Bernstein initiated coverage with an Outperform rating, noting the company's strong position in power infrastructure and massive orders for data center equipment. Despite premium valuation concerns, supply chain bottlenecks, and unprofitability in the wind segment, strong demand for power-related infrastructure is outweighing these risks.

Texas Instruments (TXN) stock increased by 5.14% on June 18, driven by an upgrade from Citi due to its dominant share in AI-related power management chips and expectations of easing trade restrictions with China. The company's strategic transition to 300-millimeter wafer manufacturing and new product innovations like EV battery monitors are also contributing factors to this surge, alongside broader positive market dynamics in the tech sector. Despite its strong performance, the stock faces risks of a significant valuation premium and potential growth deceleration as competitors resolve supply chain issues.

Hilton and the Hilton Global Foundation have launched a new nationwide partnership with Big Brothers Big Sisters of America (BBBSA) to provide mentorship, career exposure in hospitality, and transformative travel experiences to young people. Hilton will donate 250 million Hilton Honors Points, its largest-ever charitable points donation, to create travel opportunities for BBBSA youth and their families. The partnership aims to bridge the opportunity gap for young people by offering immersive career exploration in six U.S. cities, with plans to expand nationwide.

Banco de Chile has joined Corfo's Escala ProInversión guarantee program, which has already mobilized over $22.8 billion in funding for startups and innovative SMEs. This initiative provides state-backed credit coverage of up to 80% and a cap of UF 100,000, significantly lowering financial barriers for expanding businesses. The program aims to support early-stage growth, with 62 companies benefiting from over US$24 million in coverage between 2023 and 2025.

Jennifer Rumsey, CEO of Cummins, has been appointed to 3M's board of directors and its science, technology and sustainability committee, effective June 5. Rumsey, the first woman CEO of Cummins, brings expertise in driving growth through innovation and technology in global industrial markets. Her appointment aligns with 3M's strategic focus on innovation and advanced manufacturing following the spinoff of its healthcare division.

U.S. defense contractor General Dynamics (GD.N) is seeking tens of millions of dollars in legal fees after plaintiffs dropped an antitrust lawsuit that alleged the company conspired with rivals to suppress employee wages. General Dynamics claims the plaintiffs "never had a shred of evidence" and continued litigation despite evidence undermining their claims. Shipbuilder Huntington Ingalls (HII.N), also a defendant in the case, recently agreed to a $2.7 million settlement for related claims.

The FDA has expanded the label for Merck's Capvaxive pneumococcal shot to include at-risk children and adolescents aged 2-17 with chronic conditions, making it the only vaccine specifically studied and indicated for this group in the U.S. This decision was based on Phase 3 STRIDE-13 data. Capvaxive is already approved for adults 18 and older and covers serotypes linked to a significant percentage of invasive pneumococcal disease cases in at-risk children.

Nucor anticipates higher earnings for the second quarter, both sequentially and year-over-year, with all operating segments expecting increased profits. The steel mills segment is projected to see the most significant boost due to higher average selling prices and stable volumes, along with a benefit from raw material procurement cost refunds. The company’s guidance also includes a non-cash benefit from its investment in fusion energy company Helion.